Papalois, A. E., Barbatis, C., Chrysikos, D., Korontzi, M., Sideris, M., Pittaras, T., . . . Triantafillidis, J. K. (2019). Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats. Biomed Res Int.
Citação norma ChicagoPapalois, Apostolos E., Calypso Barbatis, Dimosthenis Chrysikos, Maria Korontzi, Michail Sideris, Theodoros Pittaras, Eleni Triantafyllidi, Alexandros Nomikos, and John K. Triantafillidis. "Treatment With Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats." Biomed Res Int 2019.
Citação norma MLAPapalois, Apostolos E., et al. "Treatment With Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats." Biomed Res Int 2019.